REQUEST A DEMO
Total
USD $0.00
Search more companies

Launxp Biomedical Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Launxp Biomedical Co., Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Launxp Biomedical Co., Ltd. is a company based in Taiwan, China, with its head office in Taichung City. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on September 24, 2015. 26 (2023) employees currently work for Launxp Biomedical Co., Ltd.. Its’ total assets recorded a growth of 21.11%.

Headquarters
No. 51, Sec. 2, Gongyi Rd., Nantun Dist
Taichung City; Taichung City;

Contact Details: Purchase the Launxp Biomedical Co., Ltd. report to view the information.

Website: http://www.launxp.com

Basic Information
Total Employees:
Purchase the Launxp Biomedical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Launxp Biomedical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Launxp Biomedical Co., Ltd. report to view the information.
Incorporation Date:
September 24, 2015
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
16.12%
Purchase this report to view the information.
1.42%
Purchase this report to view the information.
1.31%
Purchase this report to view the information.
0.41%
Purchase this report to view the information.
0.41%
Subsidiaries
4.20
4.2%
Company Performance
Financial values in the chart are available after Launxp Biomedical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-64.55%
EBITDA
-68.12%
Net Profit (Loss) for the Period
-64.02%
Total assets
21.11%
Total equity
21.55%
Return on Equity (ROE)
-8.3%
Quick Ratio
-5.33%
Cash Ratio
0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?